Funder
European Federation of Pharmaceutical Industries and Associations
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference29 articles.
1. European Medicines Agency. Treatments and vaccines for COVID-19. https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-COVID-19/treatments-vaccines-COVID-19.
2. European Commission. Communication From The Commission To The European Parliament, The Council, The European Economic And Social Committee And The Committee Of The Regions EU Strategy On COVID-19 Therapeutics. https://ec.europa.eu/info/sites/default/files/communication-strategy-covid-19-therapeutics_en.pdf.
3. LaVange L, Adam SJ, Currier JS, et al. Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): designing master protocols for evaluation of candidate COVID-19 therapeutics. Ann Intern Med. 2021;174:1293–300.
4. Bolislis WR, de Lucia ML, Dolz F, et al. Regulatory agilities in the time of COVID-19: overview, trends, and opportunities. Clin Ther. 2021;43:124–39.
5. Chong SSF, Kim M, Limoli M, et al. Measuring progress of regulatory convergence and cooperation among Asia-Pacific Economic Cooperation (APEC) member economies in the context of the COVID-19 pandemic. Ther Innov Regul Sci. 2021;55:786–98.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献